|
Antibiotic
|
All isolates (n = 129)
|
ST5-associated
spa
types
|
ST8-associated
spa
types
|
|---|
|
All ST5
|
t002
|
All ST8
|
t008
|
|---|
|
(n = 69)
|
(n = 52)
|
(n = 46)
|
(n = 43)
|
|---|
|
Benzylpenicillin
|
129 (100%)
|
69 (100%)
|
52 (100%)
|
46 (100%)
|
43 (100%)
|
|
Oxacillin
|
126 (98%)
|
66 (96%)
|
49 (94%)
|
46 (100%)
|
43 (100%)
|
|
Cefoxitin
|
126 (98%)
|
66 (96%)
|
49 (94%)
|
46 (100%)
|
43 (100%)
|
|
Erythromycin
|
115 (89%)
|
60 (87%)
|
49 (94%)
|
45 (98%)
|
42 (98%)
|
|
Ciprofloxacin
|
81 (63%)
|
59 (86%)
|
49 (94%)
|
20 (43%)
|
20 (47%)
|
|
Levofloxacin
|
81 (63%)
|
59 (86%)
|
49 (94%)
|
20 (43%)
|
20 (47%)
|
|
Moxifloxacin
|
81 (63%)
|
59 (86%)
|
48 (92%)
|
20 (43%)
|
20 (47%)
|
|
Clindamycin
|
61 (47%)
|
58 (84%)
|
48 (92%)
|
2 (4%)
|
2 (5%)
|
|
Inducible clindamycin
|
33 (26%)
|
33 (48%)
|
31 (60%)
|
0 (0%)
|
0 (0%)
|
|
Tetracycline
|
8 (6%)
|
4 (6%)
|
2 (4%)
|
3 (7%)
|
2 (5%)
|
|
Gentamicin
|
3 (2%)
|
2 (3%)
|
0 (0%)
|
1 (2%)
|
1 (2%)
|
- No isolates were resistant to linezolid, nitrofurantoin, quinupristin-dalfopristin, tigecycline, trimethoprim-sulphamethoxazole, and vancomycin.
